MUMBAI, India, Oct. 5 -- Intellectual Property India has published a patent application (202531031984 A) filed by Institute Of Life Sciences, Bhubaneswar; and School Of Pharmaceutical Sciences, Siksha O Anusandhan Deemed To Be on March 31, 2025, for Cinnamic Acid-Derived N-Heterocyclic Compounds (tpdm And Tf) Inhibit Sars-Cov-2 Infection And Its Method Of Preparation.
Inventors include Dr. Soma Chattopadhyay; Dr. Bharat Bhusan Subudhi; Tompe Krishna Vitthalrao; Dr. Koustav Chatterjee; Dr. Ipsita Mohanty; and Soumyajit Ghosh.
The application for the patent was published on October 02, 2026, under issue no. 40/2026.
Abstract: ABSTRACT Cinnamic acid-derived N-heterocyclic compounds (TPDM and TF) inhibit SARS-CoV-2 infection and its method o...